3.68
3.68 (0%)
As of Feb 14, 2025
Scpharmaceuticals Inc. [SCPH]
Source:
Company Overview
Scpharmaceuticals Inc is a pharmaceutical company committed to revolutionizing cardiorenal healthcare through patient-centric innovations while developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs.
| Country | United States |
| Headquarters | burlington, massachusetts |
| Phone Number | ( 617 ) 517-0730 |
| Industry | manufacturing |
| CEO | John H. Tucker |
| Website | www.scpharmaceuticals.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $36.3 |
| Operating Profit | $-64.8 |
| Net Income | $-85.1 |
| Net Cash | $0 |
Profit Ratios
| Gross Margin | $25 |
| Operating Margin | -178.3 |
| Profit as % of Revenues | -29.3% |
| Profit as % of Assets | -84.3% |
| Profit as % of Stockholder Equity | -639.3% |
Management Effectiveness
| Return on Equity | -639.3% |
| Return on Assets | -79.2% |
| Turnover Ratio | 36% |
| EBITA | $-64.8 |
Balance Sheet and Cash Flow Measures
| Total Assets | $107.5 |
| Total Liabilities | $94.2 |
| Operating Cash Flow | $0 |
| Investing Cash Flow | $0 |
| Financing Cash Flow | $0 |
